Results 141 to 150 of about 5,541,707 (291)

Microbial communities and functional diversity in seafood

open access: yesJSFA reports, EarlyView.
Abstract Functional diversity encompasses ecosystem processes that enhance adaptability to environmental change. This study explores the diversity of microorganisms associated with seafood. In this paper, we present our knowledge of microbial diversity in relation to seafood.
Christian Larbi Ayisi   +3 more
wiley   +1 more source

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops

open access: yes, 2008
Eiichi UchioDepartment of Ophthalmology, Fukuoka University School of Medicine, Fukuoka, JapanAbstract: Olopatadine hydrochloride exerts a wide range of pharmacological actions such as histamine H1 receptor antagonist action, chemical mediator ...
Eiichi Uchio
core  

Linking immune responses with fibrosis in allergic eye disease. [PDF]

open access: yesCurr Opin Allergy Clin Immunol, 2015
Dale SB, Saban DR.
europepmc   +1 more source

From nature to nanoscale: advances, challenges, and preclinical translation of nanofiber drug delivery systems containing plant‐derived active ingredients

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Since the early 1960s, nanotechnology has been a critical area of science, allowing for the development of sophisticated nanomaterials. Nanofibers, one of the most widely used nanotechnological drug delivery systems, have emerged as a highly versatile platform within modern pharmaceutical sciences.
Heybet Kerem Polat   +7 more
wiley   +1 more source

DERMACLEAR: AI‐Powered Insights Into Four Chronic Inflammatory Skin Diseases in Spain

open access: yesJEADV Clinical Practice, EarlyView.
Using an AI‐enhanced analysis of electronic health records from nearly 50,000 patients, the DERMACLEAR study provides real‐world insights into the prevalence, clinical complexity, comorbidities and treatment patterns of HS, CU, PsO and AD in Spain.
Ana Giménez‐Arnau   +11 more
wiley   +1 more source

Ethics Eye is looking for Spotters!

open access: yes
This entry includes a write-up and 2 infographics in English.On January 8, 2024, the Ethics Eye team published a three-slide post on their facebook page encouraging followers and others to join the team as external media ethics violation ...
Ethics Eye
core  

A Practical Guide for Incorporating Emollients in the Treatment of Mild‐to‐Moderate Atopic Dermatitis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Emollients and cleansers are essential components in managing atopic dermatitis (AD). While international evidence‐based guidelines recommend using gentle cleansers and emollients daily as a foundational therapy for AD, implementation in practice remains suboptimal.
Mette Deleuran   +12 more
wiley   +1 more source

MEK Inhibitor Associated Airway Injury in an Infant With Noonan Syndrome: A Case Report

open access: yesThe Laryngoscope, EarlyView.
An infant with Noonan syndrome treated with trametinib developed extensive mucosal sloughing of the upper and lower airway, followed by severe supraglottic scarring. Clinicians should consider airway toxicity as a potential adverse effect of MEK inhibitor therapy.
Veronica Drozdowski‐Nuccio   +4 more
wiley   +1 more source

Taste Dysfunction and Bell's Palsy: A Scoping Review

open access: yesThe Laryngoscope, EarlyView.
Taste dysfunction is a well‐recognized but inconsistently reported symptom in Bell's palsy. This scoping review found that taste dysfunction is prevalent in these patients, often precedes facial weakness, and commonly improves within 6 months. Standardized, longitudinal studies employing validated psychophysical measures are needed to clarify the ...
Sherina R. Thomas   +2 more
wiley   +1 more source

Ocular Motility in Thyroid Eye Disease Evaluation and Surgery

open access: yes, 2010
Evaluation of diplopia in the patient with Thyroid Eye Disease requires differentiating between monocular and binocular diplopia, both of which may occur.curriculum_fellow; IC-E4di-thyroid ...
Steven E. Feldon, MD, MBA
core  

Home - About - Disclaimer - Privacy